CalciMedica, Inc.CALCNASDAQ
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank71
Studio
Year-over-Year Change

Year-over-year research & development expense growth

Percentile
P71
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
20255.22%
2024-8.71%
202389.93%
2022-55.83%
2021-9.82%
2020-31.45%
201933.12%
20180.00%